Viewing Study NCT02238132


Ignite Creation Date: 2025-12-24 @ 9:42 PM
Ignite Modification Date: 2026-03-01 @ 8:59 PM
Study NCT ID: NCT02238132
Status: COMPLETED
Last Update Posted: 2014-09-12
First Post: 2014-09-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Airways Disease
Sponsor: Boehringer Ingelheim
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pulmonary Disease, Chronic Obstructive View
Keywords: